Six months of treatment with Trikafta (elexacaftor/tezacaftor/ivacaftor) helped open the nasal and sinus passages in people with cystic…
Articles by Lila Levinson, PhD
The U.S. approval of CFTR modulators for cystic fibrosis (CF) may have reduced or delayed the need for liver transplants…
While treatment with Kaftrio (elexacaftor/tezacaftor/ivacaftor) helps people with cystic fibrosis (CF) gain weight, a tendency toward unhealthy diets may…
One-year treatment with Trikafta — a widely used, approved medication for people with cystic fibrosis (CF) — significantly…
Northwestern University scientists developed a wearable patch that could help cystic fibrosis (CF) patients manage their disease from home. A…
The Food and Drug Administration (FDA) placed the U.S. portion of a Phase 2b trial of BX004, a treatment for…
Interim results from the first nine participants in a Phase 2 clinical trial testing Arcturus Therapeutics’ experimental inhaled therapy…
A new noninvasive prenatal test for cystic fibrosis (CF) and three other inherited conditions, launched by Natera, uses…
The first participant has been dosed in a Phase 2b clinical trial testing BiomX’s experimental inhaled therapy BX004 in adults…
Alyftrek has been approved by the European Commission to treat cystic fibrosis (CF) patients 6 years and older who…